
Revealing Rothmund-Thomson Syndrome Type 2: The Role of Genetic Testing
Unlock the potential of genetic testing in diagnosing Rothmund-Thomson Syndrome Type 2, ensuring accurate diagnosis, tailored care, and effective family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock the potential of genetic testing in diagnosing Rothmund-Thomson Syndrome Type 2, ensuring accurate diagnosis, tailored care, and effective family planning.

Explore how genetic testing aids in diagnosing adult Sandhoff disease. Identify HEXB mutations for accurate diagnosis and personalized treatment strategies.

Unravel Sandhoff disease's infantile form with genetic testing. Early diagnosis, family planning, and research advancements offer hope and potential therapies.

Explore the genetic causes of juvenile Sandhoff disease and how genetic testing aids in early diagnosis, carrier identification, and personalized management strategies.

Explore how genetic testing aids in diagnosing and managing sialidosis, a rare lysosomal storage disorder caused by NEU1 gene mutations, and its treatment potential.

Explore how genetic testing aids in diagnosing sickle cell disease, identifying carriers, and crafting personalized treatments to enhance patient outcomes effectively.

Explore how genetic testing revolutionizes the diagnosis and management of sickle cell-hemoglobin C disease, highlighting early detection and personalized treatment options.

Explore sodium channelopathy-related small fiber neuropathy, its impact, and how genetic testing aids in diagnosis, risk prediction, and personalized treatment.